DXCM: DexCom, Inc. Stock

by  •  • Comments Off on DXCM: DexCom, Inc. Stock

SIC 3841 – Surgical and Medical Instruments and Apparatus

Valuation
Market Cap ($M) 51,050.67
Enterprise Value ($M) 52,635.47
Book Value ($M) 2,246.80
Book Value / Share 5.65
Price / Book 22.72
NCAV ($M) 385.30
NCAV / Share 0.97
Price / NCAV 132.50

Profitability (mra)
Return on Invested Capital (ROIC) 0.13
Return on Assets (ROA) 0.12
Return on Equity (ROE) 0.29

Liquidity (mrq)
Quick Ratio 2.51
Current Ratio 2.90

Balance Sheet (mrq) ($M)
Current Assets 4,620.70
Assets 6,482.20
Liabilities 4,235.40
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 3,622.30
Operating Income 597.70
Net Income 541.50
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 748.50
Cash from Investing -507.20
Cash from Financing -318.60

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Vanguard Group Inc 11.51 1.48
01-25 13G/A BlackRock Inc. 8.50 -2.04

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-08 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTI
2023-10-26 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSU
2023-07-27 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT T

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 262,119 1,140,938 22.97
2024-05-02 356,504 1,215,817 29.32
2024-05-01 438,171 1,002,481 43.71
2024-04-30 378,122 1,499,553 25.22

(click for more detail)

Similar Companies
BVS – Bioventus Inc. CUTR – Cutera, Inc.
CVRX – CVRx, Inc. EMBC – Embecta Corp.
GEHC – GE HealthCare Technologies Inc.


Financial data and stock pages provided by
Fintel.io